TTNP

Titan Pharmaceuticals

Delisted

TTNP was delisted on the 1st of October, 2025.

12 hedge funds and large institutions have $722K invested in Titan Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
4
Closed
5
Calls
$58K
Puts
$36K
Net Calls
+$22K
Net Calls Change
+$176K
Name Holding Trade Value Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$386K +$4.45K +119 +1%
Morgan Stanley
2
Morgan Stanley
New York
$169K -$128K -3,416 -43%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$99K
Group One Trading
4
Group One Trading
Illinois
$28K -$27.1K -726 -49%
Renaissance Technologies
5
Renaissance Technologies
New York
$24K +$24K +650 New
UBS Group
6
UBS Group
Switzerland
$13K -$2.16K -59 -14%
TRCT
7
Tower Research Capital (TRC)
New York
$2K +$1.72K +49 +613%
TC
8
Trust Company
Kansas
$1K
APA
9
American Portfolios Advisors
New York
$43
Citadel Advisors
10
Citadel Advisors
Florida
-$179K -3,445 Closed
VF
11
Virtu Financial
New York
-$87K -1,665 Closed
Bank of New York Mellon
12
Bank of New York Mellon
New York
-$40K -770 Closed
ASN
13
Advisory Services Network
Georgia
-$23K -450 Closed